Nanoparticulate benzothiophene formulations

Details for Australian Patent Application No. 2005311731 (hide)

Owner Elan Pharma International Ltd.

Inventors Jenkins, Scott; Liversidge, Gary

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005311731

PCT Pub. Number WO2006/060698

Priority 60/633,003 03.12.04 US

Filing date 2 December 2005

Wipo publication date 8 June 2006

Acceptance publication date 23 December 2010

International Classifications

A61K 31/4535 (2006.01)

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/060698 Priority application(s): WO2006/060698

23 December 2010 Application Accepted

  Published as AU-B-2005311731

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005311732-Use of polyoxypropylene/polyoxyethylene terpene compounds in emulsion polymerization

2005311730-Methods for administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs